Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.

× No keyword cloud information.

13 in total

1. 4',6-Dimethoxyisoflavone-7-O-β-D-glucopyranoside (wistin) is a peroxisome proliferator-activated receptor α (PPARα) agonist in mouse hepatocytes.

Authors: Misato Suzuki; Fumiya Nakamura; Emi Taguchi; Maho Nakata; Fumi Wada; Momoka Takihi; Tomoyo Inoue; Shinji Ohta; Hiroyuki Kawachi
Journal: Mol Cell Biochem Date: 2018-01-09 Impact factor: 3.396

Review 2. Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance.

Authors: Evangelos Oikonomou; Konstantinos Mourouzis; Petros Fountoulakis; Georgios Angelos Papamikroulis; Gerasimos Siasos; Alexis Antonopoulos; Georgia Vogiatzi; Sotiris Tsalamadris; Manolis Vavuranakis; Dimitris Tousoulis
Journal: Heart Fail Rev Date: 2018-05 Impact factor: 4.214

3. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.

Authors: Gabriela Orasanu; Ouliana Ziouzenkova; Pallavi R Devchand; Vedika Nehra; Osama Hamdy; Edward S Horton; Jorge Plutzky
Journal: J Am Coll Cardiol Date: 2008-07-02 Impact factor: 24.094

4. Synthesis of tryptoline-3-carboxylic Acid derivatives a novel antidiabetic agent.

Authors: An Choudhary; Ms Kohli; A Kumar; A Joshi
Journal: J Young Pharm Date: 2011-04

5. In silico profiling for secondary metabolites from Lepidium meyenii (maca) by the pharmacophore and ligand-shape-based joint approach.

Authors: Fan Yi; Xiao-Lei Tan; Xin Yan; Hai-Bo Liu
Journal: Chin Med Date: 2016-09-26 Impact factor: 5.455

6. Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformatics.

Authors: Lei Liu; Ying Ma; Run-Ling Wang; Wei-Ren Xu; Shu-Qing Wang; Kuo-Chen Chou
Journal: Drug Des Devel Ther Date: 2013-04-08 Impact factor: 4.162

7. PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches.

Authors: Fiorella Malchiodi-Albedi; Andrea Matteucci; Antonietta Bernardo; Luisa Minghetti
Journal: PPAR Res Date: 2008 Impact factor: 4.964

8. Cryptochrome and Period Proteins Are Regulated by the CLOCK/BMAL1 Gene: Crosstalk between the PPARs/RXRalpha-Regulated and CLOCK/BMAL1-Regulated Systems.

Authors: Koh-Ichi Nakamura; Ikuo Inoue; Seiichiro Takahashi; Tsugikazu Komoda; Shigehiro Katayama
Journal: PPAR Res Date: 2008 Impact factor: 4.964

9. Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists?

Authors: Osman A B S M Gani
Journal: Cardiovasc Diabetol Date: 2008-03-20 Impact factor: 9.951

Review 10. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review.

Authors: Bogna Grygiel-Górniak
Journal: Nutr J Date: 2014-02-14 Impact factor: 3.271